Hermosilla, J.; Alonso-GarcÃa, A.; Salmerón-GarcÃa, A.; Cabeza-Barrera, J.; Medina-Castillo, A.L.; Pérez-Robles, R.; Navas, N.
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate. Vaccines 2023, 11, 1635.
https://doi.org/10.3390/vaccines11111635
AMA Style
Hermosilla J, Alonso-GarcÃa A, Salmerón-GarcÃa A, Cabeza-Barrera J, Medina-Castillo AL, Pérez-Robles R, Navas N.
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate. Vaccines. 2023; 11(11):1635.
https://doi.org/10.3390/vaccines11111635
Chicago/Turabian Style
Hermosilla, Jesús, Airan Alonso-GarcÃa, Antonio Salmerón-GarcÃa, José Cabeza-Barrera, Antonio L. Medina-Castillo, Raquel Pérez-Robles, and Natalia Navas.
2023. "Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate" Vaccines 11, no. 11: 1635.
https://doi.org/10.3390/vaccines11111635
APA Style
Hermosilla, J., Alonso-GarcÃa, A., Salmerón-GarcÃa, A., Cabeza-Barrera, J., Medina-Castillo, A. L., Pérez-Robles, R., & Navas, N.
(2023). Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate. Vaccines, 11(11), 1635.
https://doi.org/10.3390/vaccines11111635
